Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by jeffm34on Apr 18, 2021 4:59pm
102 Views
Post# 33019521

RE:RE:Board chair at ONC

RE:RE:Board chair at ONC

No I don't have a legal background.  I don't think a special meeting is needed right now. If we do in fact have the numbers to vote out 1 or 2 board members this go around that's all that's needed. Remove 2 board members and let it be known if credible changes aren't made quickly then a special meeting will be called with a full slate of new board members proposed.  The board is responsible for executive compensation so if we show we have the ability to change the board, you can be sure changes will be made. 


SPCEO1 wrote: Jeffm34 - I believe you were the one who posted some info about calling a special meeting at one point. Do you have some legal background or did you just work hard to dig that info up? If you are a legal type - do you anything about what might happen if you got your wish and shareholders voted many sitting board members off the board? I am assuming the remaining board members would be able to replace those who were voted off with new board members of their choosing and potentially no effective chage from our perspective. Or is there some other way for shareholders to have a bigger say in who those replacements might be?
 

jeffm34 wrote: Here's a small company from Alberta, Canada specializing in oncology.  They don't have one of several thousand ex-vps from Pfizer sitting on their board. Their board chair is Wayne Pisano who is the former president and CEO of Sanofi Pasteur.  TH refuses to look outside its small circle of friends for any help what so ever.  Nothing will change with the stock performance until that mindset is completely erased from the company. 




<< Previous
Bullboard Posts
Next >>